Related Experiment Video
Updated: Aug 11, 2025

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
Severe Thrombocytopenia in a Patient With a History of Olfactory Neuroblastoma
Avani M Singh1,2, Hailing Zhang3, Lubomir Sokol2
1Hematology and Medical Oncology, University of South Florida, Tampa, USA.
Abstract:
Olfactory neuroblastoma is a rare disease with no randomized clinical trials to guide treatment decision making. Surgery, radiation, and chemotherapy are all used for treatment, and prognosis is mostly determined by the histologic grade and clinical stage. While a neuroendocrine type of neoplasm is similar to small cell carcinoma, metastatic disease in olfactory neuroblastoma is rare. We present a case at our institution of an uncommon clinical course of relapsed olfactory neuroblastoma complicated by severe thrombocytopenia.

